In ovarian cancers, including HGSOC, the PI3K/AKT/mTOR pathway is frequently hyperactivated through various genetic alterations, driving cell proliferation, migration, and chemotherapy resistance [15,16]. Here, AKT1 is linked to ovarian carcinoma.